Skip to main content Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting No. 100
Wednesday, April 18, 2018, 4:38 p.m. to 5:42 p.m.
Presiding
Bill Casey, Chair (Liberal)

Library of Parliament
• Karin Phillips, Analyst
The Committee proceeded to the consideration of matters related to Committee business.

Motion

The Committee resumed consideration of the motion moved by John Oliver on Monday, April 16, 2018, which read as follows:

That, pursuant to Standing Order 108(2), the Committee undertake a study on the barriers to access to treatment and drugs for Canadians affected by rare diseases and disorders in order to develop recommendations on actions that the federal government can take, in partnership with the provinces and territories, to remove these barriers; that the Committee report its findings and recommendations to the House no later than December 31, 2018; and that, pursuant to Standing Order 109, the Committee request that the Government table a comprehensive response to the report.

The debate continued.

Amendment

Ben Lobb moved, — That the motion be amended by adding after the word “disorders” the following: “including the Special Access Program,”.

After debate, the question was put on the amendment of Ben Lobb and it was agreed to, by a show of hands: YEAS: 9; NAYS: 0.

The Committee resumed consideration of the motion, as amended :

That, pursuant to Standing Order 108(2), the Committee undertake a study on the barriers to access to treatment and drugs for Canadians affected by rare diseases and disorders, including the Special Access Program, in order to develop recommendations on actions that the federal government can take, in partnership with the provinces and territories, to remove these barriers; that the Committee report its findings and recommendations to the House no later than December 31, 2018; and that, pursuant to Standing Order 109, the Committee request that the Government table a comprehensive response to the report.

The question was put on the motion, as amended, and it was agreed to, by a show of hands: YEAS: 9; NAYS: 0.

Senate
• Hon. Nancy Greene Raine, Senator
Nova Scotia Department of Health and Wellness
• Robert Strang, Chief Medical Officer of Health
As an individual
• David Hammond, Professor, University of Waterloo, School of Public Health and Health Systems
• Monique Potvin Kent, Assistant Professor, Faculty of Medicine, University of Ottawa
Pursuant to the Order of Reference of Wednesday, February 14, 2018, the Committee commenced consideration of Bill S-228, An Act to amend the Food and Drugs Act (prohibiting food and beverage marketing directed at children).

David Hammond, by videoconference from Waterloo, Ontario, Dr. Robert Strang, by videoconference from Halifax, Nova Scotia, Nancy Greene Raine and Monique Potvin Kent made statements and answered questions.

At 5:31 p.m., by unanimous consent and pursuant to Standing Order 115(5), it was agreed that the Committee continue to sit.

At 5:42 p.m., the Committee adjourned to the call of the Chair.



Marie-Hélène Sauvé
Clerk of the Committee